Refractory Ventricular Tachycardia Storm: A case report and review of literature

Main Article Content

Navjyot Kaur*

Abstract

Ventricular tachycardia (VT) storm continues to be an important challenge for the cardiologists all over the globe. VT storm usually occurs in a structurally diseased heart with low left ventricular ejection fraction (LVEF) but may also occur in patients with arrhythmic syndromes like long QT syndrome, Brugada syndrome and catecholaminergic polymorphic VT who have structurally normal heart. Despite its life threatening consequences, the guidelines and literature regarding management of incessant VT is sparse. Here we present a middle age male who presented with scar related refractory VT. Unfortunately we lost the patient; but this case highlights the difficulty and challenges faced in management of hemodynamically unstable VT storm.

Downloads

Download data is not yet available.

Article Details

Kaur, N. (2019). Refractory Ventricular Tachycardia Storm: A case report and review of literature. Journal of Cardiovascular Medicine and Cardiology, 6(3), 045–050. https://doi.org/10.17352/2455-2976.000091
Case Report(s)

Copyright (c) 2019 Kaur N.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Al-Khatib SM, Stevenson WG, Ackerman MJ (2018) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 15: e190-e252. Link: http://bit.ly/2JX2rl8

Kowey PR, Levine JH, Herre JM (1995) Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 92: 3255-3263. Link: http://bit.ly/2Opbtvq

Israel CW, Barold SS (2007) Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol 12: 375-382. Link: http://bit.ly/2Mg8Dq1

Haegeli LM, Della Bella P, Brunckhorst CB (2016) Management of a Patient With Electrical Storm: Role of Epicardial Catheter Ablation. Circulation 133: 672-676. Link: http://bit.ly/2ygla4I

Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, et al. (2007) Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 4: 1395-1402. Link: http://bit.ly/2GuNzIs

Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, et al. (2001) Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 103: 2066-2071. Link: http://bit.ly/2JX7HW1

Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, et al. (2005) Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 7: 184-192. Link: http://bit.ly/2LIPu0t

Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH (1998) Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 32: 1909-1915. Link: http://bit.ly/2GyXVqO

Zaugg CE, Wu ST, Barbosa V, Buser PT, Wikman-Coffelt J, et al. (1998) Ventricular fibrillation-induced intracellular Ca2+ overload causes failed electrical defibrillation and post-shock reinitiation of fibrillation. J Mol Cell Cardiol 30: 2183-2192. Link: http://bit.ly/2YikK8o

Joglar JA, Kessler DJ, Welch PJ, Keffer JH, Jessen ME, et al. (1999) Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 83: 270-272. Link: http://bit.ly/2MkAVPZ

European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, et al. (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-346. Link: http://bit.ly/2YqBnD4

Hohnloser SH, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, et al. (2006) Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 27: 3027-3032. Link: http://bit.ly/2Y6tG5C

Santangeli P, Muser D, Maeda S, Filtz A, Zado ES, et al. (2016) Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and metaanalysis of randomized controlled trials. Heart Rhythm 13: 1552-1559. Link: http://bit.ly/2JWkaJp

Stanton MS, Prystowsky EN, Fineberg NS, Miles WM, Zipes DP, et al. (1989) Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation. J Am Coll Cardiol 14: 209-215. Link: http://bit.ly/2LJvx9I

Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM (2000) Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102: 742-747. Link: http://bit.ly/2GyYYXR

Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, et al. (1986) Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor downregulation in heart failure. Circ Res 59: 297-309. Link: http://bit.ly/2Ym2FpV

Tsagalou EP, Kanakakis J, Rokas S, Anastasiou-Nana MI (2005) Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. Int J Cardiol 99: 341-342. Link: http://bit.ly/2YmEqbk

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, et al. (2011) Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Circulation 124: 2649-2660. Link: http://bit.ly/2Y6tKCo

Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, et al. (2006) Comparison of betablockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 295: 165-171. Link: http://bit.ly/32Tpzsd

Greene M, Newman D, Geist M, Paquette M, Heng D, et al. (2000) Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2: 263-269. Link: http://bit.ly/2K7P4gP

MacMahon S, Collins R, Peto R, Koster RW, Yusuf S (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 260: 1910-1916. Link: http://bit.ly/2YpAdDu

European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, et al. (2006) ACC/ AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346. Link: http://bit.ly/2YqBnD4

Gao D, Van Herendael H, Alshengeiti L, Dorian P, Mangat I, et al. (2013) Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator. J Cardiovasc Pharmacol 62: 199-204. Link: http://bit.ly/2OmwAyo

Gorgels AP, van den Dool A, Hofs A, Mulleneers R, Smeets JL, et al. (1996) Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 78: 43-46. Link: http://bit.ly/2Yqq51z

Ortiz M, Martín A, Arribas F, Coll-Vinent B, Del Arco C, et al. (2016) PROCAMIO Study Investigators. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J 38: 1329-1335. Link: http://bit.ly/2JWkPdR

Mandel JE, Hutchinson MD, Marchlinski FE (2011) Remifentanilmidazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia. J Cardiovasc Electrophysiol 22: 464-466. Link: http://bit.ly/2MnNR85

Ogletree ML, Sprung J, Moravec CS (2005) Effects of remifentanil on the contractility of failing human heart muscle. J Cardiothorac Vasc Anesth 19: 763-767. Link: http://bit.ly/30XBtzp

Mulpuru SK, Patel DV, Wilbur SL, Vasavada BC, Furqan T (2008) Electrical storm and termination with propofol therapy: a case report. Int J Cardiol 128: e6-e8. Link: http://bit.ly/2KaQLKF

Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, et al. (2015) Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol 8: 68–75. Link: http://bit.ly/2yjBwcs

Mathuria N, Wu G, Rojas-Delgado F, Shuraih M, Razavi M, et al. (2016) Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol 48: 27-34. Link: http://bit.ly/2Y7d5i7

Meng L, Tseng CH, Shivkumar K, Ajijola O (2017) Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review. JACC Clin Electrophysiol 3: 942-949. Link: http://bit.ly/2ZdWvcB

Fudim M, Boortz-Marx R, Ganesh A (2017) Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis. J Cardiovasc Electrophysiol 28: 1460-1467. Link: http://bit.ly/2K0VqhS

Bourke T, Vaseghi M, Michowitz Y, Sankhla V, Shah M, et al. (2010) Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 121: 2255-2262. Link: http://bit.ly/30ZP09W

Ajijola OA, Lellouche N, Bourke T, Tung R, Ahn S, et al (2012) Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol 59: 91-92. Link: http://bit.ly/310JSSN

Vaseghi M, Gima J, Kanaan C, Ajijola OA, Marmureanu A, et al. (2014) Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm 11: 360-366. Link: http://bit.ly/2OimoXM

Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, et al. (2016) Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. N Engl J Med 375: 111-121. Link: http://bit.ly/2ZikSGc

Liang JJ, Muser D, Santangeli P (2017) Ventricular Tachycardia Ablation Clinical Trials. Card Electrophysiol Clin 9: 153-165. Link: http://bit.ly/2MhHqDb

Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, et al. (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 117: 462-469. Link: http://bit.ly/2SG6IMA

Di Biase L, Santangeli P, Burkhardt DJ, Bai R, Mohanty P, et al. (2012) Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 60: 132-141. Link: http://bit.ly/2YsHOW7

Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, et al. (2015) Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm 12: 1997-2007. Link: http://bit.ly/2LJ7BTW

Muser D, Santangeli P, Castro SA, Pathak RK, Liang JJ, et al. (2016) Long-Term Outcome After Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Dilated Cardiomyopathy. Circ Arrhythm Electrophysiol 9: pii e004328. Link: http://bit.ly/2YqBTRw

Baratto F, Pappalardo F, Oloriz T, Bisceglia C, Vergara P, et al. (2016) Extracorporeal Membrane Oxygenation for Hemodynamic Support of Ventricular Tachycardia Ablation. Circ Arrhythm Electrophysiol : pii: e004492. Link: http://bit.ly/2SLOtFt

Liang JJ, Betensky BP, Muser D, Zado ES, Anter E, et al. (2017) Long term outcome of surgical cryoablation for refractory ventricular tachycardia in patients with non-ischemic cardiomyopathy. Europace 20: e30-e41. Link: http://bit.ly/2MkvnoW